Assenagon Asset Management S.A. trimmed its position in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 7.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,613 shares of the aerospace company’s stock after selling 367 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Leidos were worth $665,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of LDOS. Board of the Pension Protection Fund purchased a new position in Leidos in the fourth quarter valued at $908,000. Oak Thistle LLC purchased a new position in shares of Leidos in the 4th quarter valued at about $564,000. Brookstone Capital Management raised its position in shares of Leidos by 16.7% during the 4th quarter. Brookstone Capital Management now owns 4,978 shares of the aerospace company’s stock worth $717,000 after acquiring an additional 714 shares in the last quarter. Fiduciary Alliance LLC purchased a new stake in Leidos during the fourth quarter worth approximately $736,000. Finally, Czech National Bank boosted its holdings in Leidos by 5.4% in the fourth quarter. Czech National Bank now owns 28,931 shares of the aerospace company’s stock valued at $4,168,000 after purchasing an additional 1,489 shares in the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.
Leidos Stock Performance
Shares of LDOS opened at $145.97 on Friday. The stock has a market capitalization of $19.48 billion, a P/E ratio of 16.63, a P/E/G ratio of 1.06 and a beta of 0.66. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. Leidos Holdings, Inc. has a 1 year low of $108.95 and a 1 year high of $202.90. The company’s fifty day moving average is $154.24 and its two-hundred day moving average is $158.22.
Analyst Ratings Changes
A number of analysts have weighed in on the stock. TD Cowen cut shares of Leidos from a “buy” rating to a “hold” rating and cut their price objective for the stock from $200.00 to $165.00 in a report on Wednesday, January 8th. Truist Financial reduced their price target on shares of Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a research report on Friday, November 22nd. Wells Fargo & Company decreased their price objective on shares of Leidos from $205.00 to $199.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Robert W. Baird lifted their target price on Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, Barclays upped their target price on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $179.07.
Check Out Our Latest Research Report on Leidos
Insider Transactions at Leidos
In other news, Director Surya N. Mohapatra sold 2,748 shares of Leidos stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total transaction of $535,777.56. Following the completion of the sale, the director now directly owns 20,001 shares in the company, valued at approximately $3,899,594.97. This trade represents a 12.08 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Noel B. Geer purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, November 20th. The stock was purchased at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the acquisition, the director now owns 2,000 shares in the company, valued at approximately $322,260. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.96% of the company’s stock.
About Leidos
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Articles
- Five stocks we like better than Leidos
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What is the FTSE 100 index?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.